Categories AlphaGraphs, Earnings, Other Industries
LDOS Earnings: Highlights of Leidos Holdings’ Q4 2022 results
Leidos Holdings, Inc. (NYSE: LDOS) on Tuesday reported higher earnings and revenues for the fourth quarter of 2022. The company also provided guidance for fiscal 2023.
At $3.69 billion, fourth-quarter revenues were up 6% year-over-year. Revenues of the Civil and Health segments increased in double-digits while Defense Solutions remained unchanged.
Unadjusted net income increased to $180 million or $1.28 per share in the December quarter from $176 million or $1.23 per share in the prior-year period. Adjusted profit was $1.83 per share, up 17% from last year.
For fiscal 2023, the company expects revenues to be in the range of $14.7 billion to $15.1 billion, and adjusted earnings per share to be between $6.40 and 6.80.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
